{"name":"Aerami Therapeutics","slug":"aerami-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQeHhISHVyb2Z5d2h0aGoyZW4takJhLTlQaDlYbFFlaTRvMnBrN3h6cEttemhWelM0SzRkRFlzVlkzTkdET1dqb2xZcVdjZ0pKWGZIVnd0QnBDRHJjN0J3WXZmaWRpU0g4VndCYk9zSE94dF80VWNWX01MYXpJci02SFozdHlOdlR2TkM0ckNpdjBzVHE5U2hVUzc0U0dMODBXZkNYY08xOFh1OE53eWRRYi03cUIwQlh3d0JvTU41djhNMm9Mc3hBelZldmRETjlQd3ptNmlkY2RuQm9zR1F4WlMzeVQyUnhxeDdBSUNSbjRJX1NLVjI0ZEs0bmY3dWh4dDd1TFZKbjlpNTlIeXdqdm9PWG1mS3hEMTNTTmRjZw?oc=5","date":"2025-01-20","type":"trial","source":"GlobeNewswire","summary":"Advancements in Ocular Hypertension Clinical Trial Pipeline - GlobeNewswire","headline":"Advancements in Ocular Hypertension Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNMmNBR1FYUk9mTWJEY1hlWGp3VGctQWxndHBCRWdTYUVlTVM0b2Q1N0REU2RKZlJhQWFDTmV5YzBCUk12enVHcU9FQTA4NXpaOEcwclpQZ0dQLUpaU0JrTTdJZ3JKMjNhaG9MT3I0cHFxbDE5dkZ4QWZvQXphTFpzZzdwWnUteWV4Mk9waFVFRWhyWjRaX2V4bUFLeThiT3FsTHpLX0NmUlY0MkFn?oc=5","date":"2024-08-30","type":"pipeline","source":"bizjournals.com","summary":"Durham firm raised $80 million. Now the company is gone. - bizjournals.com","headline":"Durham firm raised $80 million. Now the company is gone.","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-07-19","type":"pipeline","source":"PR Newswire","summary":"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer B","headline":"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Ba","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOVTZjOWQxS2NlYXhHcDB0cENzWGo2cVc4RVBmZl9VeklfUUFVdDk0QmI5a2VZdnh5QlQ5X0k2bkEzU0ozV091UmFwbGd0Z2l0X3JIbTVRYzE5Y0g0NVBGdVZxcXQwX01WNlp4X3JUMS1TeDZXU0F6UDZweWg0cWJzcWc4TFV6VWZWcjlv?oc=5","date":"2023-07-07","type":"pipeline","source":"pharmaphorum","summary":"Changing Faces: Pharma and biotech hires from May & June 2023 - pharmaphorum","headline":"Changing Faces: Pharma and biotech hires from May & June 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFA2UnhXVnVvTmpjMGNKSzlXT0s3dTFpaDRkMHRGRmgxTS05ZTBhaGp4RDlad3pQTFRJOHM2QlR3TnVYajVhU0F5a1l4T0h5cFNYVlpnSlBoUlVVb0M3UkNv?oc=5","date":"2023-02-15","type":"pipeline","source":"Nature","summary":"People - Nature","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMUlkbUo2d0Q0SHNwTXIzbmxqd1FDU2JHSWdVclN6ZUVOUVVsRjhJY0lvekItMGc3dV92cXV6dXFOX3NlX0pJcy0yV08ycVNVc19qcXUxOElyZVRJSEVGODBXV1JLMXE0SGhqcHlnRTRtOGcwN2V4UWstQXR6bWd3ZFB5Ml9BTXFwYlpGT0pVdG1fMktrNUhKTk96ei1FMHgzaXpGeGk0Ym8?oc=5","date":"2023-01-06","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—2 more C-suite members leave Galapagos island - Fierce Biotech","headline":"Chutes & Ladders—2 more C-suite members leave Galapagos island","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNZWhGQVgtRG52c0lLeGpjZldFZXpiM1gzaUhsb0tjR2E5QnVPZ2RrNVFrMUp2UTdyWEdPZGRraTRsM1RLV3Fpa0ZNdW0yRTNITnhXV0VxTEd6OWw4cHAtei03Tm9NRUxRU1JSNDhLRV93Yk1mU0VQamcyMGh5bEh4UEhNZWw0TDhGUkpHbHc5VEZLTVZPYlE?oc=5","date":"2022-12-21","type":"pipeline","source":"BioSpace","summary":"Aerami Therapeutics Appoints Lisa Yañez as Chief Executive Officer - BioSpace","headline":"Aerami Therapeutics Appoints Lisa Yañez as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQWUtfckZMWWFiQVZWc2N0ei1NRHpybXhwV19IU2xJd05MalB5WVhCRDJPVnNPYzhXQ2dLRWM2SERaeTNva0F1R1hNWXh1anhiTWxEZmZQMC1BdEJpZ3JxR3JqTllreTRqMHhFMldQZU0tOEdwckxzNzhQNDdHWXZZY2g1SXFCLUhVVENtSnN1dkU2UkxSUWdZajZmd2RFUEdScUlyTG53?oc=5","date":"2020-07-16","type":"trial","source":"clinicalleader.com","summary":"A Quick Transition From Research Firm To Clinical-Phase Biotech - clinicalleader.com","headline":"A Quick Transition From Research Firm To Clinical-Phase Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNeEJkSU5kaFRrVXhtbzJJQU1BRnYtNmNONEFLM3N0WXpuNEZMYnR4RTJPamhjOERHTk5EOVM2bjZrVkFGRGwzelZpaHA1UzFtVERyQ2ZFWWVTc1VfczRhRE9GUHZvSkVzT1hMMnlQeGdicFVrQ0J0elNNSWhzNGZzRzdOenVGOExzanY4endmV3BLTW83V1ZQX251VzlMOFB5X0J5WFoyQjF4dUdxeHlJ?oc=5","date":"2019-09-28","type":"pipeline","source":"Healio","summary":"Pharmaceutical company develops inhaled endocrine therapies - Healio","headline":"Pharmaceutical company develops inhaled endocrine therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQaEJIWHhlc1FXaFRmbHpKYjNzUjliUmRHYVBVR2VuRkVzUld2RGJ3R0RpSTcwNFdxRVI1bmdRRDgtNDF6U09LWWU4S3J3V19BR3BZTkQ0ZVNOaTNyaVd0VG5EaEp6X2VJSXpVNU1VOUtPOVV3Zkg1Q2o5UWdIUWZUR1poNDYyaGxobmdncw?oc=5","date":"2019-09-25","type":"pipeline","source":"Drug Delivery Business","summary":"Dance Biopharm rebrands to Aerami Therapeutics - Drug Delivery Business","headline":"Dance Biopharm rebrands to Aerami Therapeutics","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}